Scholars Central

Case reportPublished 2016

Serum Antinuclear Antibodies as Indicator of Relapse in Patients with Non- Hodgkins Lymphoma

Authors: Manal Mohamed Saber

Journal of Clinical and Cellular Immunology

Volume 7 · Issue 5 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: The association of antinuclear antibodies (ANA) has been reported in Non-Hodgkin’s lymphoma (NHL). This study was conducted to assess the serum levels of ANA in NHL patients and its relationships with prognosis. Subjects and methods: This study included 64 patients with NHL and 30 healthy controls. Enzyme-linked immunosorbent assay (ELISA) was performed to determine serum levels of ANA. Results: There were significant differences in the serum ANA between NHL patients and controls (P 0.8 (AUC: 0.876). Conclusion: Our data argue that positive ANA levels can be useful for diagnosis of relapse in NHL patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Cellular Immunology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Manal Mohamed Saber”